Here you'll find new evidence and guidance from various sources across a variety of conditions of relevance to different audiences.

Thursday, October 4th, 2018: V-BID in Diabetes Webinar

Webinar: V-BID in Diabetes At noon on Thursday, October 4th, 2018, the V-BID Center is hosting a webinar in cooperation with the Center for Workforce Health and

Population Health to Personalized Medicine: Connecting Disease Indicators to Work Outcomes - Diabetes

The CWHP report "Population Health to Personlized Medicine: Connecting Disease Indicators to Work Outcomes - Type 2 Diabetes" presents a framework for connecting disease indicators of diabetes to a variety of work outcomes including absence, job performance, work disability and permanent departure from the workforce. The framework outlines connections between clinical and employer perspectives around worker health and suggests a variety of ways to improve diagnosis and treatment for better health and work-related outcomes.

Pilot Project: Predicting Who Will Respond Best to Medical Treatments

Recent evidence shows that the results of randomized clinical trials might not apply to individual patients in a straightforward way, even to those within the trial. While randomization ensures the comparability of treatment groups overall, there remain important differences between individuals in each treatment group that can dramatically affect the likelihood of benefiting from or being harmed by a therapy. Averaging effects across such different patients can give misleading results to physicians who care for individual, not average, patients.

Does Daily Self-Monitoring of Blood Sugar Levels Improve Blood Sugar Control and Quality of Life for Patients with Type 2 Diabetes Who Do Not Use Insulin?

For the nearly 75% of patients living with type 2 diabetes (T2DM) who do not use insulin, decisions regarding self-monitoring of blood glucose (SMBG) is unclear. SMBG testing is a resource-intensive activity without firmly established patient benefits. While SMBG holds great promise for sparking favorable behavioral change, the potential for no benefit or even patient harm must be acknowledged. Possible negative effects on patient quality of life must be more closely examined along with the speculative benefits of SMBG in non-insulin–treated T2DM.

Comparing Three Methods to Help Patients Manage Type 2 Diabetes

Diabetes is a complicated disease that can cause heart attack, stroke, kidney failure, and eye problems. Patients with diabetes need to monitor their blood sugar, follow a diabetic diet, exercise regularly, take multiple medications, and get regular checkups of their blood pressure, cholesterol, eyes, and feet. To assist with organizing these tasks, a community health worker, attached to a patient’s clinic, can help patients understand the care of their diabetes and keep patients in contact with their doctors.

Diabetes Archives | Integrated Benefits Institute

Check-out IBI research and reports on diabetes